213 related articles for article (PubMed ID: 17393237)
1. The effect of inhaled budesonide and formoterol on bronchial remodeling and HRCT features in young asthmatics.
Capraz F; Kunter E; Cermik H; Ilvan A; Pocan S
Lung; 2007; 185(2):89-96. PubMed ID: 17393237
[TBL] [Abstract][Full Text] [Related]
2. Effects of formoterol-budesonide on airway remodeling in patients with moderate asthma.
Wang K; Liu CT; Wu YH; Feng YL; Bai HL; Ma ES; Wen FQ
Acta Pharmacol Sin; 2011 Jan; 32(1):126-32. PubMed ID: 21170080
[TBL] [Abstract][Full Text] [Related]
3. Effects of budesonide/formoterol combination therapy versus budesonide alone on airway dimensions in asthma.
Hoshino M; Ohtawa J
Respirology; 2012 May; 17(4):639-46. PubMed ID: 22248352
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of high-dose budesonide/formoterol (Symbicort) compared with budesonide administered either concomitantly with formoterol or alone in patients with persistent symptomatic asthma.
Jenkins C; Kolarikova R; Kuna P; Caillaud D; Sanchis J; Popp W; Pettersson E
Respirology; 2006 May; 11(3):276-86. PubMed ID: 16635085
[TBL] [Abstract][Full Text] [Related]
5. Fluticasone/formoterol combination therapy versus budesonide/formoterol for the treatment of asthma: a randomized, controlled, non-inferiority trial of efficacy and safety.
Bodzenta-Lukaszyk A; Buhl R; Balint B; Lomax M; Spooner K; Dissanayake S
J Asthma; 2012 Dec; 49(10):1060-70. PubMed ID: 23102189
[TBL] [Abstract][Full Text] [Related]
6. Budesonide/formoterol maintenance and reliever therapy in moderate-to-severe asthma: effects on eosinophilic airway inflammation.
Takeyama K; Kondo M; Tagaya E; Kirishi S; Ishii M; Ochiai K; Isono K; Tamaoki J
Allergy Asthma Proc; 2014; 35(2):141-7. PubMed ID: 24717791
[TBL] [Abstract][Full Text] [Related]
7. Airway inflammation in patients with asthma with high-fixed or low-fixed plus as-needed budesonide/formoterol.
Pavord ID; Jeffery PK; Qiu Y; Zhu J; Parker D; Carlsheimer A; Naya I; Barnes NC
J Allergy Clin Immunol; 2009 May; 123(5):1083-9, 1089.e1-7. PubMed ID: 19368965
[TBL] [Abstract][Full Text] [Related]
8. The effects of regular inhaled formoterol, budesonide, and placebo on mucosal inflammation and clinical indices in mild asthma.
Wallin A; Sandström T; Söderberg M; Howarth P; Lundbäck B; Della-Cioppa G; Wilson S; Judd M; Djukanović R; Holgate S; Lindberg A; Larssen L; Melander B
Am J Respir Crit Care Med; 1999 Jan; 159(1):79-86. PubMed ID: 9872822
[TBL] [Abstract][Full Text] [Related]
9. Additive effects of inhaled formoterol and budesonide in reducing asthma exacerbations.
Pauwels R
Allergy; 1998; 53(42 Suppl):20-3. PubMed ID: 9615842
[No Abstract] [Full Text] [Related]
10. Combined budesonide/formoterol turbuhaler treatment of asthma.
Remington TL; Heaberlin AM; DiGiovine B
Ann Pharmacother; 2002 Dec; 36(12):1918-28. PubMed ID: 12452756
[TBL] [Abstract][Full Text] [Related]
11. Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group.
Pauwels RA; Löfdahl CG; Postma DS; Tattersfield AE; O'Byrne P; Barnes PJ; Ullman A
N Engl J Med; 1997 Nov; 337(20):1405-11. PubMed ID: 9358137
[TBL] [Abstract][Full Text] [Related]
12. Effect of formoterol with or without budesonide in repeated low-dose allergen challenge.
Dahlén B; Lantz AS; Ihre E; Skedinger M; Henriksson E; Jörgensen L; Ekström T; Dahlén SE; Larsson K
Eur Respir J; 2009 Apr; 33(4):747-53. PubMed ID: 19129280
[TBL] [Abstract][Full Text] [Related]
13. Budesonide/formoterol maintenance and reliever therapy via Turbuhaler versus fixed-dose budesonide/formoterol plus terbutaline in patients with asthma: phase III study results.
Atienza T; Aquino T; Fernández M; Boonsawat W; Kawai M; Kudo T; Ekelund J; Ivanov S; Carlsson LG
Respirology; 2013 Feb; 18(2):354-63. PubMed ID: 23126237
[TBL] [Abstract][Full Text] [Related]
14. Onset of effect of budesonide and formoterol administered via one pressurized metered-dose inhaler in patients with asthma previously treated with inhaled corticosteroids.
Kaiser H; Parasuraman B; Boggs R; Miller CJ; Leidy NK; O'Dowd L
Ann Allergy Asthma Immunol; 2008 Sep; 101(3):295-303. PubMed ID: 18814453
[TBL] [Abstract][Full Text] [Related]
15. Multidetector-row computed tomography assessment of adding budesonide/formoterol to tiotropium in patients with chronic obstructive pulmonary disease.
Yasui H; Inui N; Furuhashi K; Nakamura Y; Uto T; Sato J; Yasuda K; Takehara Y; Suda T; Chida K
Pulm Pharmacol Ther; 2013 Jun; 26(3):336-41. PubMed ID: 23340058
[TBL] [Abstract][Full Text] [Related]
16. Do asthmatic smokers benefit as much as non-smokers on budesonide/formoterol maintenance and reliever therapy? Results of an open label study.
van Schayck OC; Haughney J; Aubier M; Selroos O; Ekström T; Ostinelli J; Buhl R
Respir Med; 2012 Feb; 106(2):189-96. PubMed ID: 22119455
[TBL] [Abstract][Full Text] [Related]
17. An economic evaluation of adjustable and fixed dosing with budesonide/formoterol via a single inhaler in asthma patients: the ASSURE study.
Price D; Haughney J; Lloyd A; Hutchinson J; Plumb J
Curr Med Res Opin; 2004 Oct; 20(10):1671-9. PubMed ID: 15462701
[TBL] [Abstract][Full Text] [Related]
18. Maintenance plus reliever budesonide/formoterol compared with a higher maintenance dose of budesonide/formoterol plus formoterol as reliever in asthma: an efficacy and cost-effectiveness study.
Lundborg M; Wille S; Bjermer L; Tilling B; Lundgren M; Telg G; Ekström T; Selroos O
Curr Med Res Opin; 2006 May; 22(5):809-21. PubMed ID: 16709303
[TBL] [Abstract][Full Text] [Related]
19. Bronchodilator effect of single-dose formoterol administered by pressurized metered-dose inhaler in children with asthma aged 6 to <12 years receiving budesonide.
Berger WE; Gillen M; Eckerwall G; Uryniak T; Trudo FJ; Lampl KL
Allergy Asthma Proc; 2014; 35(2):134-40. PubMed ID: 24717790
[TBL] [Abstract][Full Text] [Related]
20. Safety and tolerability of high-dose budesonide/formoterol via Turbuhaler® in Japanese patients with asthma: a randomized, double-blind, crossover, active comparator-controlled, phase III study.
Saito T; Hasunuma T
Clin Drug Investig; 2012 Jan; 32(1):51-61. PubMed ID: 22024920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
